Dissertation > Excellent graduate degree dissertation topics show

The Effect of Atorvastatin Regimen Continued Sequential Treatment on High Mobility Group Protein and Its Lipids After PCI

Author: WuPengCheng
Tutor: BaiFeng; YuJing
School: Lanzhou University
Course: Department of Cardiology
Keywords: High sensitivity C-reactive protein High mobility group protein-1 Atorvastatin Coronary artery disease
CLC: R541.4
Type: Master's thesis
Year: 2012
Downloads: 35
Quote: 0
Read: Download Dissertation


Objective To observe the effect of atorvastatin regimen continued sequential treatmenton on peripheral serum of high mobility group protein-1(HMGB-1)、high sensitivity C-reactive protein(hs-CRP) and clinical impact after percutaneous coronary intervention(PCI) in patients with coronary artery disease (CAD).Methods One handrend and one patients with CAD were randomized into three groups:group A、B、C based on the conventional therapy dosage of atorvastatin20mg/d.Group A was given20mg/d prior12hours before PCI. Atorvastatin was not taken on the moment of PCI, After PCI the patients took atorvastatin20mg/d. Group B was given40mg/d prior12hours before PCI, on the moment before PCI, patients were taken atorvastatin40mg/d, after PCI the patients were prescribed atorvastatin20mg/d. Group C was given80mg/d prior12hours before PCI and on the moment of before PCI was taken another40mg of atorvastatin, after PCI the patients took atorvastatin40mg/d. HMGB-1, hs-CRP, TC, TG, LDL-C and HDL-C were measured before, and at48th hours,4th week,12th week and24th week after PCI for follow up.Results The dosage of atorvastatin was positively correlated with LDL-C (P<0.05), but HMGB-1、hs-CRP has nonegitive correlation with TG、HDL and LDL-C (P>0.05). Before admission, at4th12th and24th week after PCI, there were no significant different in three groups among baseline HMGB-1, hs-CRP and48thhour after PCI (P>0.05), and these index in B and C group were lower than those in group A. Atorvastatin40mg/d was significantly reduced HMGB-1, hs-CRP after PCI than it20mg/d did on4th weeks and12th week (P<0.05). The concentration of HMGB-1, hs-CRP were no correlation with lipids (P>0.05). After24weeks of follow-up, B and C group had statistically significant less than group A in cardiovascular events(P<0.05). There was also no difference in group B and C. The levels of TC, TG, HDL, Liver function and renal function did not elevated significantly(P>0.05). The numbers of patients of ALT increased3times than normal in3groups were3,5and7respectively and could recover to normal after4weeks follow up. There were no myalgia, abdominal pain, bloating,constipation, discomfort, headache, skin rashes, dizziness, blurred vision,t aste barrier, muscle pain, fatigue, fever, blood creatine phosphokinase raised phenomenon etal to be found.Conclusion1. Serum inflammatory cytokines like HMGB-1and hs-CRP were elevated after PCI.2. Atorvastatin regimen continued sequential treatment could reduce postoperative inflammation.3. Atorvastatin regimen continued could safely reduce inflammation of Atorvastatin.4. Effect on certain extent anti-inflammatory effects of Atorvastatin.5. Taking40mg/d of atorvastatin regimen for24weeks is safety.

Related Dissertations

  1. The Effects of Atorvastatin on Expression of Osteopontin in Kidney of the Diabetic Rats Its Molecular Mechanism,R587.2
  2. Antioxidant Effects of Atorvastatin on Vascular Remodeling of Vascular Injury in Mice,R543
  3. Change and Value of Serum Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Acute Coronary Syndrome,R541.4
  4. The Clinical Values of 64-slice Spiral Computed Tomography Angiography to Coronary Artery Stenosis,R541.4
  5. Effects of Telmisartan on hs-CRP and HMW-adiponectinin Patients with Essential Hypertension,R544.1
  6. The Myocardial Protection Effect of High-Dose Atorvastatin Pretreatment Before Percutaneous Coronary Intervention in Acute Coronary Syndrome,R541.4
  7. Application and Significance of CISS Classification and TOAST Subtype on Ischemic Stroke (Attach 210 Cases Analysis),R743.3
  8. The Experimental Study of Atorvastatin with Neuroprotective Effects by Inhibiting MMP-9 and Upregulating TIMP-1 Expression in Rat Stroke Model of Focal Cerebral Ischemia/Reperfusion,R743.33
  9. Ankle-brachial index combined ultra- sensitivity C-reactive protein determination of the value of coronary artery disease,R541.4
  10. Individuals with type 2 diabetes, serum complement factor H, hs-CRP levels and insulin resistance study,R587.1
  11. To Analyze Association between CXCL16 and Acute Coronary Syndrome,R541.4
  12. Effects of Atorvastatin Combined with Celecoxib on the Proliferation and Apoptosis of Human Colon Cancer SW-480 Cell,R965
  13. Effect of Short-term Atorvastatin Calcium Preconditioning on Matrix Metalloproteinases during Myocardial Reperfusion in Rabbits,R965
  14. The Characteristics of Coronary Angiography in Type 2 Diabetes Mellitus Patients with Suspected Coronary Artery Disease,R587.1
  15. Effect and Mechanism of Atorvastatin on Myocardial Fibrosis in Rats after Myocardial Infarction,R542.22
  16. Relationship between Acute Hyperglycemia and Prognosis in Patients with Acute Myocardial Infarction,R542.22
  17. The Changes and the Clinical Significance of Serum Ischemia Modified Albumin, Soluble Intercellular Adhesion Molecule 1 and C-reactive Protein in Patients with Coronary Heart Disease,R541.4
  18. A Study on Expression of HMGB1 in Vascular Endothelial Cells and the Effect on Oxidative Stress by High Glucose,R587.1
  19. Different Doses of Atorvastatin Improve the Forward Blood Flow in the No-reflow Rats Associated with Inflammation,R541
  20. S100A12 in Coronary Atherosclerotic Heart Disease Expression and Significance,R541.4
  21. Study of Serum Endothelin and High Sensitivity c-reactive Protein in Type 2 Diabetic Patients with Hypertension,R587.1

CLC: > Medicine, health > Internal Medicine > Heart, blood vessels ( circulatory ) disease > Heart disease > Coronary arteries ( atherosclerosis ),heart disease (CHD)
© 2012 www.DissertationTopic.Net  Mobile